IIL begins construction of Rs 700 crore facility to make FMD vaccines

The brand-new unit will have a BSL3 facility for the manufacture of drug substances and a fill-finish capability for the production of both drug products FMD vaccine and the FMD+HS vaccine.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news